<italic>MEF2C</italic> mRNA expression and cognitive function in Japanese patients with Alzheimer's disease.
MLA
Sao, Tomoko, et al. “MEF2C MRNA Expression and Cognitive Function in Japanese Patients with Alzheimer’s Disease.” Psychiatry & Clinical Neurosciences, vol. 72, no. 3, Mar. 2018, pp. 160–67. EBSCOhost, https://doi.org/10.1111/pcn.12618.
APA
Sao, T., Yoshino, Y., Yamazaki, K., Ozaki, Y., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J., & Ueno, S. (2018). MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer’s disease. Psychiatry & Clinical Neurosciences, 72(3), 160–167. https://doi.org/10.1111/pcn.12618
Chicago
Sao, Tomoko, Yuta Yoshino, Kiyohiro Yamazaki, Yuki Ozaki, Yoko Mori, Shinichiro Ochi, Taku Yoshida, Takaaki Mori, Jun‐ichi Iga, and Shu‐ichi Ueno. 2018. “MEF2C MRNA Expression and Cognitive Function in Japanese Patients with Alzheimer’s Disease.” Psychiatry & Clinical Neurosciences 72 (3): 160–67. doi:10.1111/pcn.12618.